A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer

Published:2012-07 Issue:4 Volume:30 Page:421-427
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Chen Chung-Hsin,Yang Hung-Ju,Shun Chia-Tung,Huang Chao-Yuan,Huang Kuo-How,Yu Hong-Jeng,Pu Yeong-Shiau

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference28 articles.

1. A Prospective European Organization for Research and Treatment of Cancer Genitourinary Group Randomized Trial Comparing Transurethral Resection Followed by a Single Intravesical Instillation of Epirubicin or Water in Single Stage Ta, T1 Papillary Carcinoma of the Bladder

2. Objective response of superficial bladder tumors to intravesical treatment (including review of response of marker lesions);Bouffioux;Prog Clin Biol Res,1992

3. Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer?;Han;Urology,2006

4. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials;Sylvester;J Urol,2002

5. Intravesical bacillus Calmette-Guerin is superior to mitomycin C in reducing tumor recurrence in high-risk superficial bladder cancer: A meta-analysis of randomized trials;Shelley;BJU Int,2004

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides—Current Developments in Structure-Activity Relationship;International Journal of Molecular Sciences;2024-07-03

2. Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study;BMC Urology;2024-01-31

3. Advances in Breast Cancer Drug Discovery: A Review of Therapeutic Strategies and Studies Involving Photosensitizers, Caged Xanthones and Thiosemicarbazones Derivatives;Journal of the Brazilian Chemical Society;2024

4. Is switching intravesical chemotherapeutic agent beneficial in short-term recurrent high-risk non-muscle- invasive bladder tumors? A 5-year retrospective study;2023-07-17

5. The comparison of efficacy between the connaught and tice strains of bacillus calmette-guérin in patients with non-muscle-invasive bladder cancer in Taiwan;Urological Science;2022